Kees Kramers appointed Professor of Medication safety

7 December 2017

The appointment went into effect on 1 November 2017. Kramers' teaching and research focuses on medication safety in the hospital setting. Medication errors are one of the biggest risks for hospitalised patients. It is estimated that half of these errors could be prevented through targeted education and supervision of prescribers. The chair therefore has a strong educational orientation.

Kramers is the first Professor of Medication Safety to be appointed in Nijmegen. In the past there has been a long time close collaboration between physicians and pharmacists in Nijmegen. This collaboration is a prerequisite for medication safety.

Kees Kramers (Dirksland, 1962) received his doctorate in Medicine from the University of Leiden in 1986. From 1989 until 1996 he was trained as an internist and from 1996 to 1998 as an internist-clinical pharmacologist, both at Radboud university medical center. In 1995 he obtained his PhD at Radboud University on research into antibodies that play a role in renal failure in the autoimmune disease systemic lupus erythematodes.

Training programmes in medication safety
Since 1989 Kramers has worked at Radboud university medical center on the staff of the Department of Pharmacology-Toxicology, and from 1998 he has also been on the staff of the Department of Internal Medicine, where he is responsible for patient care and teaching and research. Since 2010 he has been seconded to the Clinical Pharmacy Department at Canisius Willhelmina Hospital (CWZ) in Nijmegen. 
In these roles he developed training programmes in medication safety for beginning physician assistants at Radboud university medical center and CWZ. He also chairs the Dutch Society for Clinical Pharmacology & Biopharmacy.

Expertise Centre
His recent achievements include the founding of the Nijmeegs Expertisecentrum voor Complexe Farmacotherapie (‘Nijmegen Expertise Centre for Complex Pharmacotherapy’), a regional partnership between hospital pharmacies, regional general practitioners and public pharmacists, and the development of a compulsory national pharmacotherapy exam for future physicians.

Related news items

Results of Q fever research widespread in the media

22 March 2018

Algemeen Dagblad, Brabants Dagblad, De Gelderlander, NOS, Radio 1, Hart van Nederland and EenVandaag paid attention to the research results concerning the long-term effects of Q fever.

read more

New Scholarships available for Clinical Development course starting April 9

21 March 2018

Blended course (online + on-campus) Clinical Development, scholarships and €500,000 ZonMw grant.

read more

Call RIHS Junior Researcher 2019

21 March 2018

In 2019 funding will be made available for 6 RIHS Junior Researcher projects. The call for these PhD grants is now open.

read more

Smart use of artificial intelligence increases reading efficiency of breast ultrasound

20 March 2018

Jan van Zelst and Ritse Mann showed the results of their research in European Radiology.

read more

Radboud Talks: finals pitch competition

19 March 2018

On Monday night 16 April, the finalists from all different faculties of Radboud University and Radboudumc will compete for the grand jury prize and the audience award in LUX Nijmegen.

read more

Dutch L’Oréal UNESCO For Women in Science fellowships 2019

14 March 2018

The fellowship allows excellent female scientists to boost their scientific career. Two fellowships of 25.000 euros are available to women active in the field of life sciences, who have between 3 and 10 years post-PhD academic experience (comparable to Veni/Vidi level).

read more